A dressing may comprise a manifold having a first planar surface and a second planar surface opposite the first planar surface, and a first layer adjacent to the first planar surface and a second layer adjacent to the second planar surface. The first layer and the second layer may be laminated to the first planar surface and the second planar surface, respectively. Pressure-responsive fluid restrictions through at least one of the first layer and the second layer may be adjacent to the manifold. The first layer and the second layer may also form a sleeve or an envelope around the manifold in some embodiments. At least one of the first layer and the second layer may be configured to be disposed between the manifold and a tissue site in use. In some examples, the dressing may have a smooth or matte surface configured to contact a tissue site.

Dressing embodiments may include a first layer comprising a polymer film having a plurality of perforations, and a second layer comprising a manifold. In some embodiments, the second layer may have a length of at least 12 centimeters. In some embodiments, the second layer may have a thickness of between 7 millimeters and 10 millimeters. In some embodiments, the manifold may comprise a plurality of slits configured to provide conformability. The manifold may also be configured to maintain at least 80% of an applied negative pressure through the length.

An adhesive composition comprising silicone adhesives and one or more absorbent fillers such as hydrocolloids is disclosed. The adhesive composition is particularly well suited for use in negative pressure wound therapies.

Apparatuses and dressing components for tissue treatment with negative pressure and methods of making and using the dressings and dressing components are disclosed. For example, an apparatus for managing fluid from a tissue site may comprise at least two fluid pathways formed along the length of the apparatus. The apparatus may have at least one hinge line spanning along the length of the apparatus between at the at least two fluid pathways, and the apparatus may be curved about the hinge line. Some examples of the apparatus may comprise multiple layers assembled in a stacked relationship, which may be bonded together using weld lines to define at least two fluid pathways along the length of the apparatus. In some examples, the apparatus may be curved about the weld lines.

A micro-negative pressure foam dressing and a manufacturing method thereof is disclosed, the dressing comprises a exothermic agent layer, an isolation component covering on the exothermic agent layer, an elastic memory piece disposed under the exothermic agent layer, a liquid absorbing negative pressure pad disposed under the elastic memory piece, a contact layer disposed under the liquid absorbing negative pressure pad, a sealing film disposed between the liquid absorbing negative pressure pad and the contact layer, and a bottom release film disposed under the contact layer; and in this invention, heat generated by a exothermic agent layer causes an elastic memory piece to expand downward to compress a foam layer, and after the heat dissipates completely, a micro-negative pressure is generated since a sealed environment is formed by a sealing film, a contact layer and a wound surface without a need for the VSD negative pressure technology.

Disclosed herein are several embodiments of a negative pressure appliance and methods of using the same in the treatment of wounds. Some embodiments are directed to improved filter assemblies for use with in a canister for collecting wound exudate from a wound site, the canister comprising a filter and a shield configured to protect the filter from components within the interior of the canister.

Dressings and kits for use in wound therapy and negative-pressure therapy comprising a manifold layer comprising porous open-cell liquid permeable foam and a polymer composition The polymer composition comprises a polymer and an active agent, such as collagen and oxidized regenerated cellulose. The foam may be felted. Methods of making and using the dressings are also provided.

Vacuum dressings with a guide tube are provided for implantable medical devices that inhibit infection associated with in-dwelling devices while encouraging healing of the incision around the device. The vacuum dressings mitigate pooling of fluids that harbor bacteria from between the outer diameter of an inserted implantable medical device and the inner diameter of a guide tube and also in the cylindrical gap, between the outer diameter of an inserted implantable medical device and the inner wall of the subcutaneous tunnel, which remains in fluid communication with skin microflora. Implantable medical devices may also illustratively include a variety of catheters, such as venous access, peritoneal dialysis, and other indwelling venous access catheters that require skin penetration; cannulas; Steinman pins; Kirschner wires; and cardiac assist device lines.

A cover layer for a vacuum wound therapy dressing includes a backing layer formed from a flexible polymeric membrane and an adhesive layer for affixing the backing layer over a wound bed to provide a substantially fluid-tight seal around a perimeter of the wound bed. The cover layer is reinforced with a reinforcement layer extending to a peripheral region of the backing layer to distribute forces associated with evacuating a reservoir, as defined by or within the cover, to stimulate healing of the wound bed.

This disclosure describes devices, systems, and methods related to oxygenated hemoglobin, the generation thereof, and the use thereof. An exemplary oxygenated hemoglobin therapy system includes an oxygen source configured to provide oxygen and a hemoglobin source configured to provide topical hemoglobin. The therapy system may also include a mixer which has a first inlet, a second inlet, and an outlet. The mixer is configured to mix the oxygen and the topical hemoglobin to form a mixture and to provide the mixture to a dressing via the outlet. The therapy system may further include the dressing. The oxygenated hemoglobin therapy systems described herein are suitable for use in medical devices, such as bandages, drapes, dressings, and wound closures.